Sildenafil to facilitate weaning from inhaled nitric oxide and mechanical ventilation in a patient with severe secondary pulmonary hypertension and a patent foramen ovale

Respir Care. 2011 Oct;56(10):1611-3. doi: 10.4187/respcare.01147. Epub 2011 Apr 19.

Abstract

We describe the case of a woman who presented to the intensive care unit with acute respiratory failure that required mechanical ventilation. She had severe pulmonary hypertension secondary to interstitial lung disease, and her history included sarcoidosis and tuberculosis. She was dependent on inhaled nitric oxide (INO) to maintain safe arterial oxygen saturation and could not be weaned from mechanical ventilation. Echocardiography revealed a patent foramen ovale with substantial right-to-left shunt, which probably contributed to her hypoxemia. Sildenafil enabled weaning from INO and substantially reduced the flow through the patent foramen ovale. She was successfully extubated and discharged home. To our knowledge, this is the first report of weaning from INO and mechanical ventilation in a patient with both severe secondary pulmonary hypertension and a right-to-left shunt through a patent foramen ovale.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bronchodilator Agents / administration & dosage*
  • Comorbidity
  • Dyspnea / etiology
  • Female
  • Foramen Ovale, Patent / epidemiology
  • Humans
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / epidemiology
  • Hypertension, Pulmonary / therapy*
  • Nitric Oxide / administration & dosage*
  • Phosphodiesterase 5 Inhibitors / administration & dosage
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Piperazines / administration & dosage
  • Piperazines / therapeutic use*
  • Purines / administration & dosage
  • Purines / therapeutic use
  • Respiratory Insufficiency / etiology*
  • Sarcoidosis, Pulmonary / complications
  • Sildenafil Citrate
  • Sulfones / administration & dosage
  • Sulfones / therapeutic use*
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use*
  • Ventilator Weaning / methods*

Substances

  • Bronchodilator Agents
  • Phosphodiesterase 5 Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Nitric Oxide
  • Sildenafil Citrate